SA
Go ProLog In
VYGR
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
20 analysts·High coverage
71
Score
17 Buy (85%)3 Hold (15%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1785%
Hold
315%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$8.00
+112.5%
Consensus
$18.00
+378.1%
Bull
$18.00
+378.1%
12-Month Target Range20 analysts
$8.00$18.00$18.00
Current $3.77Consensus
Current Price
$3.77
Upside to Consensus
$14.23

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+32.58%
EPS—
FY2028
Rev+13.21%
EPS—
FY2029
Rev+38.05%
EPS—

Earnings Surprises

Recent Analyst Actions

Mar 12, 2025Wells Fargo
Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo
Target:$10.00
+162.8%from $3.81
Nov 13, 2024Oppenheimer
Oppenheimer Reiterates Outperform Rating on Voyager Therapeutics (VYGR)
Target:$18.00
+160.1%from $6.92
Sep 25, 2024Robert W. Baird
Baird Reiterates Outperform Rating on Voyager Therapeutics (VYGR)
Target:$18.00
+198.0%from $6.04
May 14, 2024Wedbush
Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
Target:$8.00
-5.7%from $8.48
Jan 2, 2024Wells Fargo
Wells Fargo Upgrades Voyager Therapeutics (VYGR) to Overweight
Target:$14.00
+55.6%from $9.00
May 10, 2023Truist Financial
Voyager Therapeutics' Seasoned Management And Leading Adeno-Associated Virus Capsid Platform Impress Bullish Analyst
Target:$18.00
+82.2%from $9.88

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance